The rise of Viagra initially drove a period of growth for major pharmaceutical companies, but recent shifts present a murky picture for shareholders. Generic competitors are reducing revenue, and persistent litigation https://leatgus941217.blog-gold.com/58514600/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet